XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net sales $ 2,749 $ 5,964 $ 7,460 $ 13,082
Cost of sales 2,186 4,588 5,951 9,331
Gross profit 563 1,376 1,509 3,751
Operating expenses:        
Product development 404 401 1,427 996
Selling, general, and administrative 1,968 2,003 6,454 6,003
Restructuring 1 (16) (21) (44)
Total operating expenses 2,373 2,388 7,860 6,955
Loss from operations (1,810) (1,012) (6,351) (3,204)
Other expenses (income):        
Interest expense 177 124 520 344
Gain on forgiveness of PPP loan 0 0 (801) 0
Loss on extinguishment of debt 0 159 0 159
Other income - employee retention tax credit (862) 0 (862) 0
(Gain) loss from change in fair value of warrants 0 (153) 0 2,274
Other expenses 15 25 47 67
Loss before income taxes (1,140) (1,167) (5,255) (6,048)
Benefit from income taxes 0 (2) 0 (2)
Net loss $ (1,140) $ (1,165) $ (5,255) $ (6,046)
Net loss per common share - basic and diluted        
Net loss, basic (USD per share) $ (0.22) $ (0.35) $ (1.22) $ (1.89)
Net loss, diluted (USD per share) $ (0.22) $ (0.35) $ (1.22) $ (1.89)
Weighted average shares of common stock outstanding:        
Basic (in shares) [1] 5,086 3,308 4,309 3,196
Diluted (in shares) [1] 5,086 3,308 4,309 3,196
[1] * Shares outstanding for the nine months ended September 30, 2020 have been restated for the 1-for-5 reverse stock split effective June 11, 2020.